TY  - JOUR
AU  - Moreno-Torres, Irene
AU  - González-García, Coral
AU  - Marconi, Marco
AU  - García-Grande, Aranzazu
AU  - Rodriguez-Esparragoza, Luis
AU  - Elvira, Víctor
AU  - Ramil, Elvira
AU  - Campos-Ruíz, Lucía
AU  - García-Hernández, Ruth
AU  - Al-Shahrour, Fatima
AU  - Fustero-Torre, Coral
AU  - Sánchez-Sanz, Alicia
AU  - García-Merino, Antonio
AU  - Sánchez López, Antonio José
PY  - 2018
DO  - 10.3389/fimmu.2018.01693
SN  - 1664-3224
UR  - http://hdl.handle.net/20.500.12105/6601
AB  - Background: Fingolimod is a functional sphingosine-1-phosphate antagonist approved for the treatment of multiple sclerosis (MS). Fingolimod affects lymphocyte subpopulations and regulates gene expression in the lymphocyte transcriptome. Translational...
LA  - eng
PB  - Frontiers Media
KW  - RNA-seq
KW  - Biomarkers
KW  - Fingolimod
KW  - Lymphocyte subpopulations
KW  - Multiple sclerosis
KW  - Transcriptome
TI  - Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study
TY  - journal article
ER  -